Get in touch

Tiefenbacher New Market Launch: Buprenorphine Patches in South Africa

Tiefenbacher Group - A smiling older man with a gray beard sits while a woman stands behind him, hugging him. Text reads, "LAUNCH OF BUPRENORPHINE IN SOUTH AFRICA." The TIEFENBACHER PHARMACEUTICALS logo is at the top, highlighting expertise in generic medicines manufacturing.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in South Africa. We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. That’s why we are thrilled to share that we have successfully prepared the launch of the generic version […]

Tiefenbacher Pharmaceuticals Launch: Varenicline in UK

Tiefenbacher Group - A woman in a blue knit hat and winter coat stands outdoors with eyes closed. Text reads, "Launch of Varenicline in the United Kingdom." The TIEFENBACHER Pharmaceuticals logo, a family-owned pharmaceutical company, appears at the top left.

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the United Kingdom We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of Varenicline in the UnitedKingdom! WHO has added Varenicline to the […]

Tiefenbacher Pharmaceuticals New Market Launch: Amifampridine

Tiefenbacher Group - An older couple dressed in winter gear stands smiling on a snowy mountain with trekking poles. The Tiefenbacher Pharmaceuticals logo highlights the launch of Amifampridine across Europe by this family-owned pharmaceutical company.

Tiefenbacher Pharmaceuticals Successfully Prepares the Launch of Amifampridine Across Europe At Tiefenbacher Pharmaceuticals, we are deeply committed to making high-quality, life-changing medications affordable and accessible to patients worldwide, regardless of, nationality, or income. That’s why we are excited to share that we have successfully prepared the launch of Amifampridine Tablets 10mg. This is the first generic […]

Tiefenbacher Group wishes you a happy new year!

Tiefenbacher Group - White text on a blue background reads "Tiefenbacher Group" with a circular dotted logo to the left, highlighting "A Year in Review" and their commitment to pharmaceutical healthcare solutions.

As 2024 draws to a close, the Tiefenbacher Group wishes you a Happy New Year and likes to share some of the year’s highlights with you. This year we celebrated many achievements: several international launches of prescription medicines, the preparation for Bilastine’s over-the-counter entry in Germany, the renovation of our Hamburg offices, and the construction […]

Tiefenbacher Pharmaceuticals New Market Launch: Ezetimibe/Atorvastatin

Tiefenbacher Group - Smiling older man outdoors, wearing a blue vest and carrying a backpack. Text: "Launch of Ezetimibe / Atorvastatin in European Union." Family-owned pharmaceutical company focused on patient-centric drug development. TIEFENBACHER PHARMACEUTICALS logo at the top.

Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared […]

Tiefenbacher Pharmaceuticals First to Market Launch: Varenicline in Europe

Tiefenbacher Group - A young woman stands outdoors with her eyes closed and hands on her chest, appearing calm and content. Text reads: "Launch of Varenicline across European Union." Tiefenbacher Pharmaceuticals, a family-owned pharmaceutical company, logo is at the top.

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of the only available Varenicline containing product in Europe. WHO has […]

Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher Group - An older smiling couple embraces outdoors. The image features the logo "Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, and a banner reading "Launch of the analgesic buprenorphine in Australia.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled […]

Tiefenbacher New Market Launch: Bilastine as Oral Dispersible Tablet (ODT)

Tiefenbacher Group - A young girl with a flower crown sits in a field of wildflowers, holding a tissue to her nose. Text reads: "Launch of the antihistamine bilastine as oral dispersible tablet—a finished dosage form." TIEFENBACHER PHARMACEUTICALS logo appears above.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in GermanyAs the allergy season is in full swing, we at Tiefenbacher Group are thrilled to announce that we have successfully prepared the launch of our latest anti-allergy medicine, Bilastine Oral Dispersible Tablet (ODT) in Germany, which is now available […]

Tiefenbacher first-to-market launch: Rivaroxaban

Tiefenbacher Group - A smiling older couple embraces outdoors in a garden, looking happy and relaxed. The man wears a blue shirt; the woman, a light pink top. The "Tiefenbacher Pharmaceuticals" logo highlights their family-owned pharmaceutical company in the upper left corner.

Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Rivaroxaban.   […]

Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher Group - A smiling older woman with short gray hair joyfully gives a piggyback ride to a laughing older man outdoors, highlighting Tiefenbacher Pharmaceuticals' commitment to generic medicines manufacturing. The company logo is in the top left corner.

Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in CanadaWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled to share that […]

Tiefenbacher New Market Launch: generic launch Teriflunomide

Tiefenbacher Group - A smiling woman in a navy raincoat stands on a beach, holding her hood. The AET TIEFENBACHER PHARMACEUTICALS logo appears in the top left, reflecting their focus on patient-centric drug development. The background shows the sea and greenery.

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]

Tiefenbacher Generic Launch: antihistamine Bilastine

Tiefenbacher Group - A smiling young man in a blue shirt lies on his back in green grass with his hands behind his head, reflecting the patient-centric drug development focus of Tiefenbacher Pharmaceuticals. The company’s logo appears in the top left corner.

Generic Launch: Tiefenbacher Pharmaceuticals successfully launches the antihistamine Bilastine for a market entry as over-the-counter (OTC) medicine in germanyGeneric drugs: As the allergy season is starting, we at Tiefenbacher Pharmaceuticals are thrilled to announce that we have successfully prepared the launch of the antihistamine Bilastine for a market entry as Over-the-counter (OTC) medicine in Germany. […]

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

Tiefenbacher Group - A smiling woman in a green top and backpack stands with arms outstretched before lush mountains and fields. The logo and text "Tiefenbacher Pharmaceuticals" highlights their pharmaceutical healthcare solutions in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are excited to share that we have successfully prepared the launch of the generic version of Apremilast […]

Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer

Tiefenbacher Group - An older man with gray hair smiles while sitting on a couch, wearing a light gray shirt. The logo and name "AET Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, is visible in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at Tiefenbacher Pharmaceuticals aim to improve peoples´ lives around the world by making medicines better affordable, better available, and better than before! That´s why we are excited to share that we have successfully prepared the […]

Tiefenbacher Pharmaceuticals New Market Launch: Apixaban anticoagulant

Tiefenbacher Group - An older man with gray hair, wearing a yellow long-sleeve shirt and backpack, walks in a lush riverside landscape. In the corner, the logo and text read "AET TIEFENBACHER PHARMACEUTICALS," a family-owned pharmaceutical company.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the anticoagulant medicine Apixaban in CanadaWe at Tiefenbacher Pharmaceuticals are driven by enabling people around the world a better access to more affordable high-quality medicines. That´s why we are happy to share that we have successfully prepared the launch of the generic version of Apixaban for […]

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

Tiefenbacher Group - Two older women smiling and hugging outdoors, both appearing joyful. The logo and text “AET TIEFENBACHER PHARMACEUTICALS” is visible in the top left corner, highlighting patient-centric drug development.

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available and affordable to as many people as possible around the world. Therefore Tiefenbacher Group is happy to share that we have successfully prepared the launch of […]

Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban

Tiefenbacher Group - A young man and an older man in patterned shirts and a hat smile together outdoors. The AET Tiefenbacher Pharmaceuticals logo appears in the top left corner, highlighting expertise in pharmaceutical healthcare solutions.

Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available for all patients around the world – irrespective of their origin or nationality. That´s why we are happy to share that we have successfully […]

Tiefenbacher Pharmaceuticals New Market Launch: Teriflunomide

Tiefenbacher Group - A smiling woman in a blue rain jacket takes a selfie outdoors by a rocky river, holding her hood with one hand. Trees and misty mountains are in the background. The Tiefenbacher Pharmaceuticals logo highlights patient-centric drug development.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE MULTIPLE SCLEROSIS MEDICINE TERIFLUNOMIDE IN CANADAWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are happy to share that we have successfully prepared the launch of the generic version […]

Tiefenbacher Pharmaceuticals New Market Launch: Lacosamide

Tiefenbacher Group - A smiling man gives a piggyback ride to a woman by the sea, both looking happy. The TIEFENBACHER PHARMACEUTICALS logo appears in the top left corner, representing family-owned pharmaceutical company values. The background shows water, grass, and a cloudy sky.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE EPILEPSY MEDICINE LACOSAMIDE IN AUSTRALIAWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their income level or nationality. That´s why we are happy to share that we have […]

Tiefenbacher Pharmaceuticals: Launch of first generic version of the antihistamine Bilastine

Tiefenbacher Group - A smiling woman with long hair stands in a field of yellow flowers under a clear sky. The Tiefenbacher Pharmaceuticals logo in the top left highlights their dedication to patient-centric drug development and innovative pharmaceutical healthcare solutions.

New market launch: TIEFENBACHER PHARMACEUTICALS successfully launches first generic version of the antihistamine BilastineWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable for all patients irrespective of their income level or nationality. That´s why we are excited to share that we have successfully launched the first generic version of Bilastine (20 […]

TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)

Tiefenbacher Group - A group of five older adults, three men and two women, stand close together outdoors, smiling and laughing under leafy trees on a sunny day, reflecting the joy that patient-centric drug development brings to thriving communities in a lush park setting.

TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has successfully developed a global dossier for a generic version of Teriflunomide 7 mg and 14 mgfilm-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. Teriflunomide […]

Get in touch